RPS Recap: Progress in the Treatment of Diabetic Eye Disease
By: Andrew E. Mathis, PhD, Medical Editor
First in a series recapping research and analysis presented at our annual meeting
Peer-Reviewed: Intraocular Pressure Changes After Removal of Sub-Tenon’s Triamcinolone Acetonide Depot
By: Miguel A. Busquets, MD, FACS; Nikolai S. Ždrale, MD; John P. Nairn, MD; Kelley Kidwell; Ji-In Choi; Richard D. Day, PhD
Early Favorable SD-OCT Response to Treatment of Diffuse DME
By: Kevin K. Suk, MD; Harry W. Flynn, Jr., MD
Early treatment response in four patients with diffuse DME receiving either grid/focal laser photocoagulation or intravitreal triamcinolone
Progression and Regression of Retinoschisis in a Single Patient
By: Harvey Lincoff, MD; Vimal Sarup, MD; Dominik Uram, MD; Ingrid Kreissig, MD
Upfront
By: Jason S. Slakter, M.D.
Global perspective
Subspecialty News
By: Jerry Helzner, Senior Editor
Why fellows chose retina; medical offices — rent space or buy?; NEI research on anti-VEGF for DME; and more
Journal Club
Recent noteworthy studies to stimulate discussion and debate
Eyes of the World
By: Ichiro Maruko, MD; Tomohira Iida, MD
Clinical implications of unique RAP/PCV prevalence patterns in Asian patients
Coding Q&A
By: Riva Lee Asbell
Clearing up Medicare questions on intravitreal injection reimbursement
Focus On
By: Leslie Goldberg, Associate Editor
Ellex’s Eye Cubed: It’s all about the image
Clinical Trial Spotlight
By: Andrew E. Mathis, PhD, Medical Editor
For whom the cell tolls